Trial Profile
Available - Avastin in Addition to Platinum-based Chemotherapy is Indicated for First-line Treatment of Patients With Locally Advanced, Metastatic or Recurrent Non-small Lung Cancer Other Than Predominantly Squamous Cell Histology
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Sep 2019
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Adenocarcinoma; Non-small cell lung cancer
- Focus Adverse reactions
- Acronyms Available; AVAiLABLE NIS
- Sponsors Roche
- 06 Nov 2015 New trial record